K. Gempel

发表

Rapid determination of total homocysteine in blood spots by liquid chromatography-electrospray ionization-tandem mass spectrometry.

K. Gempel, K. Gerbitz, B. Casetta, 2000, Clinical chemistry.

Treatment of glycogenosis type V with ketogenic diet

K. Gempel, M. Vorgerd, Hanns Lochmüller, 2005, Annals of neurology.

Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation

H. Prokisch, D. Berg, K. Gempel, 2008, Journal of Neurology.

Coenzyme Q10 deficiency and isolated myopathy

S. Dimauro, K. Gempel, Hanns Lochmüller, 2006, Neurology.

Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients

B. Schlotter-Weigel, K. Gempel, H. Lochmüller, 2007, Neuromuscular Disorders.

Adult‐onset glycogen storage disease type 2: clinico‐pathological phenotype revisited

K. Gempel, Hanns Lochmüller, R. Horvath, 2007, Neuropathology and applied neurobiology.

Subcutaneous microdialysis for children - safe biochemical tissue monitoring based on a minimal traumatizing no touch insertion technique.

K. Gempel, F. Baumeister, V. Busch, 2005, European journal of medical research.

Detection of neonatal argininosuccinate lyase deficiency by serum tandem mass spectrometry

K. Gempel, K. Gerbitz, M. Bauer, 2001, Journal of Inherited Metabolic Disease.

Monitoring of Ketogenic Diet for Carnitine Metabolites by Subcutaneous Microdialysis

K. Gempel, V. Busch, A. Hack, 2006, Pediatric Research.

In-Vitro Carboxymethylation of Low Density Lipoprotein Alters its Metabolism Via the High-Affinity Receptor

E. Schleicher, K. Gempel, K. Gerbitz, 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Short-Term Effects of Growth Hormone on Lipolysis, Glucose and Amino Acid Metabolism Assessed in Serum and Microdialysate of Healthy Young Men

K. Gempel, M. Wurm, J. Sass, 2019, Experimental and Clinical Endocrinology & Diabetes.

Immunolocalization of the Glycoxidation Product Nɛ-(carboxymethyl) Lysine in Normal and Inflamed Human Intestinal Tissues

E. Schleicher, K. Gempel, A. Nerlich, 2005 .

Cystic renal dysplasia as a leading sign of inherited metabolic disease

K. Gempel, E. Mayatepek, F. Distelmaier, 2007, Pediatric Nephrology.

"Adult" form of muscular carnitine palmitoyltransferase II deficiency: manifestation in a 2-year-old child

K. Gempel, K. Gerbitz, M. Bauer, 2001, European Journal of Pediatrics.

The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.

S. Dimauro, H. Prokisch, K. Gempel, 2007, Brain : a journal of neurology.

Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations.

K. Gempel, R. Horvath, T. Berger, 2006, Archives of neurology.

Genetic and structural characterization of the human mitochondrial inner membrane translocase.

A. Reichert, K. Gempel, K. Gerbitz, 1999, Journal of molecular biology.

Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.

B. Burwinkel, K. Gempel, K. Gerbitz, 1999, Biochemical and biophysical research communications.

Mitochondrial Disorders. A Diagnostic Challenge in Clinical Chemistry

K. Gempel, K. Gerbitz, M. Bauer, 1999, Clinical chemistry and laboratory medicine.

Mitochondria and Diabetes: Genetic, Biochemical, and Clinical Implications of the Cellular Energy Circuit

K. Gempel, K. Gerbitz, D. Brdiczka, 1996, Diabetes.

Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene.

T. Meitinger, T. Strom, H. Lehrach, 1998, Human molecular genetics.

Tandem mass spectrometric assay for the determination of carnitine palmitoyltransferase II activity in muscle tissue.

K. Gempel, K. Gerbitz, M. Bauer, 2002, Analytical biochemistry.

Acute Valproate Poisoning: Pharmacokinetics, Alteration in Fatty Acid Metabolism, and Changes During Therapy

K. Gempel, K. Gerbitz, W. Steimer, 2005, Journal of clinical psychopharmacology.

Investigation of citrullinemia type I variants by in vitro expression studies

K. Gempel, T. Vogl, J. Häberle, 2008, Human mutation.

Lipopolysaccharide and ceramide docking to CD14 provokes ligand‐specific receptor clustering in rafts

G. Schütz, T. Hartung, K. Gempel, 2001, European journal of immunology.

Screening for Carnitine Palmitoyltransferase II Deficiency by Tandem Mass Spectrometry

S. Kiechl, J. Willeit, K. Gempel, 2002, Journal of Inherited Metabolic Disease.

Production and Characterization of Antibodies against Carboxymethyllysine-modified Proteins

E. Schleicher, K. Gempel, E. Wagner, 2005 .

Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA)

H. Prokisch, K. Gempel, Hanns Lochmüller, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Uptake, clearance and metabolism of TEGDMA in guinea pigs.

R. Hickel, K. Gempel, K. Kunzelmann, 2002, Dental materials : official publication of the Academy of Dental Materials.

Biological clearance of HEMA in guinea pigs.

R. Hickel, K. Gempel, K. Kehe, 2002, Biomaterials.

[Glycogenesis Type II (M. Pompe). Selective failure of the respiratory musculature--a rare first symptom].

K. Gempel, W. Haupt, E. Neuen‐Jacob, 2006, Der Nervenarzt.

Adult carnitine palmitoyltransferase II deficiency: Detection of characteristic carnitine esters in serum by tandem mass spectrometry

K. Gempel, K. Gerbitz, M. Bauer, 1999, Journal of Inherited Metabolic Disease.

Mitochondria and Diabetes: Genetic, Biochemical, and Clinical Implications of the Cellular Energy Circuit

K. Gempel, K. Gerbitz, D. Brdiczka, 1996, Diabetes.